Vaccitech is a clinical stage T cell immunotherapy company developing products to treat and prevent cancer and infectious diseases. The company’s proprietary technology platform, comprising 
Chimpanzee Adenovirus (prime) and MVA (boost) is exceptional at inducing, boosting and maintaining CD8+ and CD4+ T cells, as well as antibodies.

Biotechnology

Vaccitech

Vaccitech's headquarters in United Kingdom

This department focuses on conducting scientific research and development to advance knowledge and innovation.

Research Division

The Research & Development team at Vaccitech focuses on advancing the company's proprietary T cell immunotherapy platform. This involves designing and developing viral vectors, optimizing RNA discovery, ensuring robust manufacturing processes, and conducting comprehensive analytical and synthetic immunotherapy research. Their work aims to create effective therapies and vaccines for cancer and infectious diseases.

Research & Development

This department oversees the strategic direction and governance of the organization.

Board Governance

This department manages financial planning, analysis, and systems to support organizational decision-making.

Finance Operations

This department oversees the planning, execution, and delivery of programs, ensuring alignment with organizational goals.

Program Management

This department ensures that products meet quality standards and regulations through systematic testing and evaluation of processes and suppliers.

People (3)

Jobs (0)

Other teams

Research & Development

Board Governance

Finance Operations

Program Management

Quality Assurance